Renaissance Technologies
THC icon

Renaissance Technologies’s Tenet Healthcare THC Stock Holding History

Renaissance Technologies’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-35,263
Closed -$4.74M – 3896
2025
Q1 		$4.74M Sell
35,263
-403,300
-92% -$53.1M 0.01% 1470
2024
Q4 		$55.4M Buy
438,563
+373,988
+579% +$55.6M 0.08% 289
2024
Q3 		$10.7M Sell
64,575
-141,800
-69% -$21.4M 0.02% 1010
2024
Q2 		$27.5M Buy
+206,375
New +$24.8M 0.05% 476
2021
Q2 		– Sell
-138,375
Closed -$7.2M – 3771
2021
Q1 		$7.2M Buy
138,375
+37,400
+37% +$1.89M 0.01% 1418
2020
Q4 		$4.03M Buy
100,975
+79,200
+364% +$2.56M ﹤0.01% 1725
2020
Q3 		$534K Sell
21,775
-624,200
-97% -$15.9M ﹤0.01% 2795
2020
Q2 		$11.7M Buy
645,975
+106,500
+20% +$2.1M 0.01% 1132
2020
Q1 		$7.77M Buy
539,475
+511,200
+1,808% +$14.7M 0.01% 1315
2019
Q4 		$1.07M Sell
28,275
-16,800
-37% -$503K ﹤0.01% 2591
2019
Q3 		$997K Buy
+45,075
New +$960K ﹤0.01% 2593
2019
Q1 		– Sell
-212,475
Closed -$3.64M – 3695
2018
Q4 		$3.64M Buy
+212,475
New +$5.14M ﹤0.01% 1920
2017
Q1 		– Sell
-1,325,875
Closed -$19.7M – 3404
2016
Q4 		$19.7M Buy
+1,325,875
New +$23.8M 0.03% 797
2015
Q4 		– Sell
-197,675
Closed -$7.3M – 3424
2015
Q3 		$7.3M Buy
197,675
+159,900
+423% +$8.26M 0.02% 1130
2015
Q2 		$2.19M Buy
+37,775
New +$1.93M 0.01% 2006
2015
Q1 		– Sell
-339,175
Closed -$17.2M – 3342
2014
Q4 		$17.2M Buy
339,175
+270,700
+395% +$14.1M 0.04% 593
2014
Q3 		$4.07M Buy
+68,475
New +$3.82M 0.01% 1275
2014
Q1 		– Sell
-63,075
Closed -$2.66M – 3009
2013
Q4 		$2.66M Sell
63,075
-184,700
-75% -$8.04M 0.01% 1593
2013
Q3 		$10.2M Sell
247,775
-174,800
-41% -$7.31M 0.02% 790
2013
Q2 		$19.5M Buy
+422,575
New +$18.9M 0.05% 455

Other funds holding THC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Renaissance Technologies's THC Position: Q2 2025 in Review

Renaissance Technologies sold out of Tenet Healthcare (THC) in Q2 2025, closing a stake of 35,263 shares — an estimated $4.74M sold.

Renaissance Technologies first reported a position in THC in Q2 2013 and held it in 20 quarters. The position peaked at $55.4M in Q4 2024. 626 funds tracked by Wall St. Rank hold THC as of Q2 2025.

  • Renaissance Technologies reported no remaining Tenet Healthcare position as of Q2 2025 after selling out during the quarter.
  • Renaissance Technologies sold 35,263 Tenet Healthcare shares in Q2 2025, an estimated $4.74M.
  • Renaissance Technologies first reported a position in Tenet Healthcare in Q2 2013 and held it in 20 quarters.
  • Renaissance Technologies's Tenet Healthcare position peaked at $55.4M in Q4 2024.
  • 626 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2025.

Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.